baber/WOPTO huggingface dataset:
Patent DK-1293198-T3 (DK)
Inventor: DRESSEN FRANK DR
IPC: A61K31/403
Filed: 2001-09-14
Granted: 2005-06-06
Abstract: This invention provides a device containing a compound of formula (I)   <CHEM>  wherein   R represents a saturated or unsaturated C2-7 aliphatic acyl group optionally substituted by one or more halogen atoms, a hydroxy group, a C1-6 alkoxy group, a carboxyl group, a C2-7 alkoxycarbonyl group, a 5 to 7-membered cycloalkyl group, a phenyl or naphthyl group; a C2-6 hydroxyalkyl group; an aliphatic acyloxyalkyl group having a C2-7 acyl group and a C1-6 alkyl group; a C1-6 alkyl group substituted by a C1-6 alkoxy group, a carboxyl group, a C2-7 alkoxycarbonyl group, a C2-7 alkoxycarbonyl group substituted by a phenyl or naphthyl group, a carbamoyl group, a mono- or di-(C1-6 alkyl)-substituted carbamoyl group or a cyano group; a benzoyl or naphthoyl group optionally substituted by one or more halogen atoms; a furoyl group or a pyridylcarbonyl group; and R<1> represents a C1-6 alkyl group optionally substituted by one or more halogen atoms, a phenyl or a naphthyl group; the carbon atom marked "*" represents a carbon atom in (R)-configuration, (S)-configuration or a mixture thereof. The TTS is efficient in the treatment of urinary tract disorders, such as benign prostatic hypertrophy.
Patent DK-1238628-T3 (DK)
Inventor: KOEPKE WOLFGANG
IPC: A61B5/0478
Filed: 2001-03-09
Granted: 2007-09-10
Abstract: The invention relates to a device for determining acoustically evoked brain potentials in brainstem audiometry from electrodes applied to the head of a subject, where the device comprises a plurality of electrodes, i.e. at least one pickup electrode and a reference electrode, to be applied at different points of the head, where the device comprises means for determining the impedance between the electrodes and the head as well as means for visually indicating a level of impedance or delivering this information to the connected audiometer. <IMAGE>
Patent DK-1250292-T3 (DK)
Inventor: HELDAL MIKAL
IPC: C12N7/00
Filed: 2001-01-04
Granted: 2004-03-29
Abstract: A method and a device for the restriction of blooms of micro-organisms in an aqueous system are described. A smaller portion of the body of water in the system is subjected to a radiation treatment, preferably a UV-treatment, whereupon the treated quantity of water is returned to the aqueous system. The UV radiation will induce activation of latent viruses, and when these are returned to the water system, micro-organisms in this system will be killed or inactivated, and new micro-organisms will not be formed.
Patent DK-1276831-T3 (DK)
Inventor: GREANEY MARK ALAN
IPC: C10G21/16
Filed: 2001-03-20
Granted: 2007-09-24
Abstract: An embodiment of the present invention is a method for isolating conducting polymer precursors by contacting a non-basic heterocyclic nitrogen containing hydrocarbon stream having a boiling point of from 232° C. (450° F.) to 566° C. (1050° F.) with an effective amount of a treating agent selected from monohydroxyl alcohols having a density at 25° C. of less than 0.90 g/cm<3 >and mixtures thereof, at conditions effective to maintain the reactants in a liquid phase to produce a first stream enriched in non-basic heterocyclic nitrogen containing hydrocarbon compounds and a second treated stream having a decreased non-basic heterocyclic nitrogen content. Optionally, an effective amount of mineral acid may be added to the hydrocarbon stream to enhance the process.
Patent DK-1182199-T3 (DK)
Inventor: ISOZUMI KEISUKE
IPC: C07C269/04
Filed: 2001-04-02
Granted: 2009-08-24
Abstract: The present invention aims at providing a process for producing an amic acid ester useful as an intermediate for agrochemical, easily at a low cost industrially. The present invention provides a process for producing an amic acid ester represented by the following general formula (7): <CHEM> (wherein A is a substituted or unsubstituted lower alkylene group or the like; R1 is a substituted or unsubstituted lower alkyl group or the like; and R3 is a hydrogen atom or a lower alkyl group), which process comprises reacting, in the presence of water, an amino acid represented by the following general formula (1): <CHEM> (wherein A has the same definition as given above) with a halogenated carbonic acid ester represented by the following general formula (2):   <CHEM> (wherein R1 has the same definition as given above and X is a halogen atom) to form an amide compound represented by the following general formula (3): <CHEM> (wherein A and R1 have the same definitions as given above), then reacting the amide compound with a halogenated carbonic acid ester represented by the following general formula (4): <CHEM> (wherein R2 is a substituted or unsubstituted lower alkyl group or the like; and X is a halogen atom) to form, in the system, a mixed acid anhydride represented by the following general formula (5) : <CHEM> (wherein A, R1 and R2 have the same definitions as given above), and reacting the mixed acid anhydride with an amine compound represented by the following general formula (6): <CHEM> (wherein R3 has the same definition as given above and Het is a substituted or unsubstituted heterocyclic group).
Patent DK-1236386-T3 (DK)
Inventor: BESSON PATRICK
IPC: A01B21/08
Filed: 2002-02-28
Granted: 2005-11-28
Abstract: The soil working tool comprises a disc (1) mounted on a bearing (3) and is installed on a chassis of the working machine by means of a support (4). The bearing carries a second disc (2) of smaller diameter than the first disc. The bearing is connected to the support with its axis inclined to the ground. The concave part of the smaller diameter disc is directed toward the bearing while the concave part of the larger disc is directed outwards. An independent claim is included fro a work machine.
Patent DK-1391511-T3 (DK)
Inventor: KUROIWA YOSHIMI
IPC: C12N15/87
Filed: 2002-05-10
Granted: 2008-09-29
Abstract: The present invention relates to a human artificial chromosome which is genetically transmissible to the next generation with high efficiency and the method for using the same. More specifically, the present invention relates to: a human artificial chromosome in which an about 3.5 Mb to about 1 Mb region containing an antibody » light chain gene derived from human chromosome 22 is bound to a chromosome fragment which is transmissible to a progeny through a germ line of a non-human animal, said chromosome fragment is derived from another human chromosome; a non-human animal carrying the human artificial chromosome and an offspring thereof; a method for producing the non-human animal; a method for producing a human antibody using the non-human animal or an offspring thereof; and a human antibody-producing mouse carrying the human artificial chromosome.
Patent DK-1436060-T3 (DK)
Inventor: TOLLEY DEREK COLIN
IPC: B01D24/14
Filed: 2002-10-15
Granted: 2008-02-04
Abstract: A method of filtering liquid media comprises directing liquid to be filtered into a vessel under pressure and draining filtered liquid media from the filtration vessel. In backwash mode liquid is forced through filter media effecting rotating flow and fluidisation of the filter media, and in normal operation liquid present in the vessel above the filter media is caused to undergo rotating flow about the vessel. The drain arrangement includes a plurality of radially extending limbs configured to act as backwash liquid distribution means in backwash mode or filtered liquid collection means in normal filter mode. In backwash mode, liquid is distributed in a direction transverse to the longitudinal direction of the respective limbs; and/or the majority of the limbs direct water either clockwise or anticlockwise.
Patent DK-1427830-T3 (DK)
Inventor: FERRARA NAPOLEONE
IPC: A61P35/00
Filed: 2002-08-27
Granted: 2012-07-23
Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Further more, method of treatment using Bv8 polypeptides are provided.
Patent DK-1480843-T3 (DK)
Inventor: PENGG AEGYD
IPC: B60C27/10
Filed: 2003-01-27
Granted: 2007-05-07
Abstract: An anti-skid chain comprising a chain mesh (LAU) and a retaining device (HAL) which is connected thereto and which, when mounted, is connected to form a ring arranged on an inner side flank (FLA) of a tyre. A locking part (VE1, VE2) is respectively arranged on both ends of the retaining device (HAL). Both locking parts (VE1, VE2) can be connected to each other. The chain mesh (LAU) is tensed on the outer side of the tyre by at least one tensing/retaining device. The two locking parts (VE1, VE2) have a plate-type base (BA1, BA2) and can be moved into a locked position (SPO) wherein they engage with each other in a detachable manner. The base (BA1) of a first locking part (VE1) is provided with a retaining lug (NAS). Opposite-lying web-type elements (ST1,ST2) protrude from the base (BA2) of the second locking part (VE2) and are used to guide the base (BA1) of the first locking part (VE1) into the locked position (SPO).
Patent DK-1476029-T3 (DK)
Inventor: MOEN EINAR
IPC: A23K1/00
Filed: 2003-02-12
Granted: 2008-02-11
Abstract: A method for producing a feedstuff or feedstuff component, e.g., a palatability-enhancing agent, said method comprising subjecting a microbial culture which comprises a methanotrophic bacterium to autolysis.
Patent DK-1599215-T3 (DK)
Inventor: BARTELS-ARNTZ MARJOLEINE MARIA THEODORA GERARDA
IPC: A23L33/20
Filed: 2003-02-07
Granted: 2010-11-15
Abstract: The novel use of peptides derived from whey protein hydrolysate as active ingredient in a medicament or as food ingredient for elevating the cholescystokinin level in the blood, and for preventing or treatment of overweight and/or obesity, in an animal, including human, in need thereof.
Patent DK-1478579-T3 (DK)
Inventor: CONWAY JOHN KELSHAW
IPC: B65D73/00
Filed: 2003-02-06
Granted: 2009-06-29
Abstract: A medicament container and a method of manufacturing the container housing at least one individual dose of medicament using a carrier having first and second opposing faces and through walls defining a through hole extending between the first and second opposing faces, the method including inserting the carrier into a mould having an element for protrusion into the through hole from the first face so as to define with the through walls a generally cup-shaped space, filling the generally cup-shaped space with a mould material so as to form a generally cup-shaped insert in the through hole, removing the carrier and insert from the mould, depositing an individual dose of medicament in the generally cup-shaped insert, and sealing the medicament and insert in the through hole by sealing first and second sheets respectively with the first and second faces.
Patent DK-1490252-T3 (DK)
Inventor: FANTAZI ALAIN
IPC: F16D65/28
Filed: 2003-03-21
Granted: 2006-03-27
Abstract: For the assembly of a spring-type brake cylinder, a rear cylinder is provided with a preloaded spring, with a rear piston and with an intermediate flange. Then, a front cylinder, in which a front piston with an actuating rod for a brake element of the braking system is movably arranged, is fixed to the rear cylinder, so that the rear cylinder and the front cylinder are in contact with one another by means of a sliding rod passing through the intermediate flange. As a result, the front piston is displaceable by the rear piston.
Patent DK-1539266-T3 (DK)
Inventor: SPECK ULRICH
IPC: A61M25/10
Filed: 2003-08-26
Granted: 2008-08-11
Abstract: A drug delivering medicinal device (A) for selective therapy of particular diseased tissue segments or organ parts comprises a device to be contacted (for at least a short period) under pressure with the diseased region, carrying on the surface a lipophilic, water-insoluble drug (I) which bonds with tissue components, such that (I) is released immediately on contact with tissue. An independent claim is included for the preparation of (A).
Patent DK-1527483-T3 (DK)
Inventor: BINDIG REINER
IPC: H01L41/293
Filed: 2003-07-18
Granted: 2008-02-11
Abstract: In external electrodes on piezoceramic multi-layer actuators, high tensile stresses act during operation on the insulating region below the base metallic coating. Problems are caused by the linking of the electrode with a conductive connection, via which the electric voltage is to be supplied. The soldering or welding process reinforces the external electrode, which thus loses elasticity at the soldering or welding point. During operation, mechanical shear stresses then occur beneath said soldering or welding points, as the electrode region lying above no longer expands. After several million operating cycles, this causes the external electrode together with the base metallic coating to become detached, thus leading to the failure of the component. The invention is characterised in that the external electrode ( 23, 24; 26, 27 ) consists of alternating layers of conductive materials ( 19 ) and non-conductive materials ( 22, 25 ), located one on top of the other, that one of the two outer layers of conductive materials ( 19 ) is connected to the base metallic coating ( 11 ) of the actuator ( 1 ) and the other is connected to the supply conductor ( 6 ) for the voltage, and that the layers of conductive materials ( 19 ) are interconnected in a conductive manner.
Patent DK-1745257-T3 (DK)
Inventor: MOGENSEN NIS
IPC: F41H5/013
Filed: 2005-04-20
Granted: 2009-06-22
Abstract: A covering of the kind serving for bulletproof armoring of a wall and including a number of bulletproof plates. The covering furthermore includes a support having a base for mounting on the wall, and a number of pockets arranged to keep the plate in positions, in which they overlap or adjoin each other in twos. This advantageously results in the fact that the walls of a container can be covered with bulletproof plates easily and quickly without leaving a space through which shots can be fired.
Patent DK-1896044-T3 (DK)
Inventor: JANG JAE-DEOG
IPC: C12N5/071
Filed: 2005-06-27
Granted: 2011-06-20
Abstract: A compound for bone forming and a method for producing the same are provided using a mixture of an osteoblast and a bio-matrix. The method comprises: isolating osteoblasts from bone tissue and culturing the isolated osteoblasts to prepare an osteoblast suspension; and mixing the resulting osteoblast suspension with a bio-matrix to prepare an osteoblast therapeutic agent. A bone formation method is provided that results in no clinical graft rejection, and is capable of achieving effective and rapid bone formation via injection of a compound which has been pre-shaped to a certain extent, so as to alleviate problems associated with bone tissue formation in unwanted regions resulting from escape of injected osteoblasts from the targeted site for bone formation and then propagation thereof to other sites via the blood stream, which are caused by injection of an osteoblast suspension.
Patent DK-1838653-T3 (DK)
Inventor: MANE JEAN
IPC: C07C35/205
Filed: 2006-01-13
Granted: 2010-11-29
Abstract: A compound of formula (I); its structure represented with dotted lines being either cis- or trans-double bonds wherein: A) R1 represents a hydrogen atom and R2 represents an OH, OCH3 or OC2H5 group while either a) R4, R5, and R7 each represent hydrogen atoms with R3, R6, and R8 each representing methyl radicals; b) R4, R6, and R7 each represent hydrogen atoms with R3, R5, and R8 each representing methyl radicals; or c) R3, R6 and R7 each represent hydrogen atoms with R4, R5, and R8, each representing methyl radicals; or B) R7 represents a hydrogen atom; R1, R4, and R6 each represent hydrogen atoms with R2, R3, and R5 each representing a methyl radical while R8 represents OH, OCH3 or OC2H5 groups when dotted lines are present; when dotted lines are absent, R8 represents either OCH3 or OC2H5 groups. At least one compound is applied as an odorant agent.
Patent DK-2014285-T3 (DK)
Inventor: KAWANISHI YASUYUKI
IPC: A61K31/421
Filed: 2000-11-21
Granted: 2010-06-28
Abstract: Neuropeptide Y5 receptor antagonist comprises new or known aminosulfinyl or aminosulfonyl derivatives (I). Neuropeptide Y5 receptor antagonist comprises aminosulfinyl or aminosulfonyl derivatives of formula (I), their prodrugs, salts or solvates. [Image] R 1optionally substituted lower alkyl, cycloalkyl or aryl, or R 1 + R 2lower alkylene; n : 1 or 2; X : (CR 3R 4) pA(CR 5R 6) q, HetU, NR 2X or optionally substituted lower alkylene, lower alkenylene, CO-lower alkylene or CO-lower alkenylene; A : optionally substituted cycloalkylene, cycloalkenylene, bicycloalkylene, arylene or divalent heterocycle; p, q : 0 or 1; Het : piperidinediyl, piperazinediyl, pyridinediyl, pyrazinediyl, pyrrolidinediyl or pyrrolediyl all attached to NR 2 via N; U : a bond, lower alkylene or lower alkenylene; Y : OCONR 7, CONR 7, CSNR 7, NR 7CO or NR 7CS; R 2-R 7H or lower alkyl; Z : optionally substituted lower alkyl, lower alkenyl, amino, lower alkoxy, carbocyclyl or heterocyclyl. Independent claims are also included for compounds (I), their salts, prodrugs and solvates in which: (i) X = 2-6C alkylene or 3-6C alkenylene; and R 1 = optionally substituted 3-10C alkyl or 5 or 6C cycloalkyl; provided that when Y = NR 7, the Z is not lower alkylphenylamino, lower hydroxyalkylphenylamino or acylphenylamino; (ii) A = heteroarylene or optionally substituted cycloalkylene, cycloalkenylene, bicycloalkylene or piperidinylene; and R 1 = optionally substituted 3-10C alkyl or 5 or 6C cycloalkyl; and (iii) A = p-phenylene; R 1 = 3-10C alkyl or 5 or 6C cycloalkyl and Z = p-lower alkylphenylene; provided that when R 1 = isopropyl, the Z is not p-n-butylphenylene. ACTIVITY : Anorectic; antidiabetic; hypotensive; antilipemic; antiarteriosclerotic; cardiant. MECHANISM OF ACTION : Neuropeptide-Y5 antagonist. In assays, a compound of formula (Ia) exhibited IC 50 values for neuropeptide Y5 binding of 0.1 nM and for cAMP in Chinese hamster ovary cells of 1.9 nM. [Image].
Patent DK-2217773-T3 (DK)
Inventor: MADEC YVES
IPC: B01J35/00
Filed: 2008-10-24
Granted: 2012-05-21
Abstract: Depolluting facing for a building structure, e.g. a roofing membrane, including a first and a second layer. The first layer (3) acting as base for the at least second layer (2) wherein the second layer consist of granules (2) comprising NOx reducing anatase titanium dioxide. The first layer may constitute a bituminous membrane or a panel made up from plastic or metal. The granules may be fixed to the roofing membrane by pressing or calandering on the hot bituminous blend embedding the granules in the bituminous membrane. The granules can be made of anatase titanium dioxide and a mineral binder, for example silicate or phosphate.
Patent DK-2215726-T3 (DK)
Inventor: ROBERTSON TIMOTHY
IPC: H04B1/034
Filed: 2008-11-26
Granted: 2018-04-09
Abstract: Transbody communication systems employing communication channels are provided. Various aspects include, for example, an in vivo transmitter to transmit an encoded signal; a transbody functionality module to facilitate communication of the encoded signal; and a receiver to receive the encoded signal. Methods and apparatus are also provided.
Patent DK-2352453-T3 (DK)
Inventor: HOEY MICHAEL
IPC: A61B18/04
Filed: 2009-11-06
Granted: 2018-06-14
Abstract: A prostate ablation system is described. The system comprises: a vapor generator; and a vapor delivery probe operatively coupled to the vapor generator and adapted to be inserted transurethrally into a prostate adjacent to a prostatic urethra of a patient, the vapor delivery probe adapted to deliver condensable vapor from the vapor generator into the prostate to deliver between 100 and 10,000 Joules to the prostate to ablate the prostate without ablating the prostatic urethra.
Patent DK-2253551-T3 (DK)
Inventor: D AMATO GIANFRANCO
IPC: B65D3/28
Filed: 2007-09-26
Granted: 2013-09-08
Abstract: A multi-layered container (1) has an inner wall (3), an outer wall (2), an opening (10) and a bottom (11). The outer wall (2) comprises a predetermined removable wall section (4) which discloses an information and which comprises an edge in an access section. This edge facilitates the separation of the wall section by a user to unhinge or remove same. To provide a cost-effective and simple container with good insulation properties and with wall section that is easy to handle, a compartment is provided between the inner and the outer walls (2,3) for thermal insulation and the wall section as an integrated component of the outer wall is a removable card, which projects into the area of the access section.
Patent DK-2294928-T3 (DK)
Inventor: LYNGLEV GITTE BUDOLFSEN
IPC: A23L5/20
Filed: 2003-10-10
Granted: 2014-11-10
Abstract: The formation of acrylamide during heat treatment in the production of a food product is reduced by treating the raw material with an enzyme before the heat treatment. The enzyme is capable of reacting on asparagine or glutamine (optionally substituted) as a substrate or is a laccase or a peroxidase.
Patent DK-2366734-T3 (DK)
Inventor: HEATER PAUL LEWIS
IPC: C08L67/02
Filed: 2006-10-06
Granted: 2017-04-18
Abstract: A polymer composition and wall of a container made from such composition is set forth comprising a polyamide and polyester and a sufficient amount of an interfacial tension reducing agent such that the polyamide domains stretch disproportionately to the amount of stretch experienced by the polyester both with and without a cobalt salt.
Patent DK-2450272-T3 (DK)
Inventor: ROHDEN ROLF
IPC: B63H9/02
Filed: 2006-06-16
Granted: 2018-03-12
Abstract: The ship has a beam (30) and a set of magnus rotors (10). Individually controlled electric motors are arranged for rotating the magnus rotors, where each electric motor is associated with each of the magnus rotors. A static frequency changer is associated with each of the electric motors for controlling speed and/or rotary direction of the electric motors. Three loading spaces provided in the ship are arranged one above the other.
Patent DK-2511301-T3 (DK)
Inventor: CARTLIDGE SUSAN ANN
IPC: C12N15/63
Filed: 2007-08-02
Granted: 2018-03-12
Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to ErbB2, preferably human ErbB2. In another embodiment, the antibodies or antigen-binding portions thereof inhibit ErbB2. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins or portions thereof derived from human anti-ErbB2 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-ErbB2 antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention
Patent DK-2723394-T3 (DK)
Inventor: OLBRICH CARSTEN
IPC: A61K51/04
Filed: 2012-06-21
Granted: 2018-08-13
Abstract: The invention is directed to formulations of lipophilic Amyloid beta ligand stilbene and more particularly to formulations which are capable to be administered parenterally e.g. intravenously, wherein the lipophilic Amyloid beta ligand stilbene is a fluorinated stilbene. Further, the invention is directed to a method for sterile filtration of formulations suitable for PET imaging of mammals pursuant to the invention.